glp 1 therapies GLP-1 Essentials GLP-1-based therapies, including GLP-1, GLP-1R

Current pharmacotherapies, including GLP-1 receptor agonists (GLP-1RAs), primarily target a single receptor and signaling pathway

Most recently, a study reported that Lingonberry (Vaccinium vitis-idaea L.) which is rich in ACN could improve NAFLD by reducing hepatic lipid accumulation, oxidative stress and inflammatory response, and might be mediated through the biosynthesis restoration of Nrf2 and glutathione (Hewage et al., 2021)

Upon binding to the erythropoietin receptor (EpoR, located on the surface of erythroid progenitor cells), EPO activates Jak2/STAT5, Ras/Raf/MEK/ERK and PI3K/Akt signaling pathways [41, 42] with consequent downstream recruitment of GATA-1 transcription factor [43], a master regulator of erythropoiesis critically affecting all aspects of cell survival and proliferation

G., & Bickel, W

J.SchwerdtleT